HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 303 filers reported holding HAEMONETICS CORP in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,952,338 | +140.5% | 111,100 | +122.2% | 1.15% | +47.3% |
| Q1 2023 | $4,137,500 | -33.5% | 50,000 | -47.6% | 0.78% | -26.3% |
| Q2 2022 | $6,225,000 | -65.0% | 95,500 | -71.5% | 1.06% | -48.3% |
| Q4 2021 | $17,768,000 | +25.9% | 335,000 | +67.5% | 2.04% | +18.9% |
| Q3 2021 | $14,118,000 | – | 200,000 | – | 1.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LGT CAPITAL PARTNERS LTD. | 1,216,059 | $64,500,000 | 1.72% |
| HEARTLAND ADVISORS INC | 406,192 | $21,544,000 | 1.26% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $10,608,000 | 1.22% |
| Aurora Investment Counsel | 32,149 | $1,705,000 | 1.01% |
| Endurant Capital Management LP | 73,914 | $3,920,000 | 0.95% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 135,000 | $7,160,000 | 0.82% |
| ARMISTICE CAPITAL, LLC | 872,000 | $46,251,000 | 0.76% |
| Summit Creek Advisors LLC | 131,357 | $6,967,000 | 0.70% |
| Dean Capital Management | 15,309 | $812,000 | 0.70% |
| Keene & Associates, Inc. | 11,720 | $622,000 | 0.54% |